Lipid Alterations in Chronic Nonspecific Low Back Pain in the Chinese Population: A Metabolomic and Lipidomic Study
Open Access
- 5 November 2024
- journal article
- research article
- Published by MDPI AG in Bioengineering
- Vol. 11 (11) , 1114
Abstract
Chronic nonspecific low back pain (cNLBP) accounts for approximately 90% of low back pain cases, affecting 65–80% of the population and significantly impacting life quality and productivity. This condition also leads to substantial financial burden. Although there have been advancements, a comprehensive understanding of the underlying etiology of cNLBP remains elusive, resulting in less than optimal treatment outcomes. This study aimed to examine the correlation between lipid variations and the development of cNLBP. The cohort consisted of 26 healthy volunteers (HV group) and 30 cNLBP patients, with an assessment of metabolites and lipid composition in both groups. Metabolomic results revealed significant alterations in lipid-associated metabolites between the HV and cNLBP groups. Subsequent lipid analysis revealed that monoacylglycerols (MAGs) increased approximately 1.2-fold (p = 0.016), diacylglycerols (DAGs) increased approximately 1.4-fold (p = 0.0003), and phosphatidylserine (PS) increased approximately 1.4-fold (p = 0.011). In contrast, triacylglycerol (TAG) decreased to about 0.7-fold (p = 0.035) in the cNLBP group compared to the HV group. The contrasting trends in MAG/DAG and TAG levels indicated that the imbalance between MAG/DAG and TAG may have an impact on the development of cNLBP. This study has provided new insights into the relationship between the progression of cNLBP and specific lipids, suggesting that these lipids could serve as therapeutic targets for cNLBP.Keywords
Funding Information
- Guangdong-Hong Kong Technology and Innovation Cooperation Funding (2023A0505010014, 20241053, 2023A04J2223)
- Research Foundation of Guangdong Provincial Bureau of Traditional Chinese Medicine (2023A0505010014, 20241053, 2023A04J2223)
- Guangzhou Municipal Science and Technology Project (2023A0505010014, 20241053, 2023A04J2223)
This publication has 60 references indexed in Scilit:
- Metabolomics in chronic pain researchEuropean journal of pain, 2020
- Rapid lipidomic profiling based on ultra-high performance liquid chromatography–mass spectrometry and its application in diabetic retinopathyAnalytical and Bioanalytical Chemistry, 2020
- Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disordersActa Pharmaceutica Sinica B, 2020
- Lipidomic identification of plasma lipids associated with pain behaviour and pathology in a mouse model of osteoarthritisMetabolomics, 2020
- Proteome-based systems biology in chronic painJournal of Proteomics, 2019
- Serum metabolomics for early diagnosis of esophageal squamous cell carcinoma by UHPLC-QTOF/MSMetabolomics, 2016
- Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network CohortEBioMedicine, 2016
- The transition from acute to chronic pain: understanding how different biological systems interactCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2013
- Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitors Produce Anti-Allodynic Effects in Mice Through Distinct Cannabinoid Receptor MechanismsThe Journal of Pain, 2010
- Metabolic Phenotyping in Health and DiseaseCell, 2008